-
When the Food and Drug Administration (FDA) approved Plan B Emergency Contraception (EC) for over-the-counter use in 2006, it opened up a new way for young men to be involved in preventing unintended pregnancy.
-
Check your last 10 patient charts. Chances are at least one patient reported a urinary tract infection (UTI). What was your chosen method of treatment?
-
New data confirms the safety of the quadrivalent human papilloma virus (HPV4) vaccine.
-
Is development of a HIV vaccine still important with such established HIV prevention approaches as male and female condom use, voluntary medical male circumcision, and pre-exposure prophylaxis (PrEP) now in place to limit exposure to HIV and reduce infectiousness?
-
You have just prescribed the selective progesterone receptor modulator emergency contraceptive pill (ECP), ulipristal acetate (ella, Watson Pharma, Morristown, NJ), to the patient sitting in front of you.
-
-
Your neighborhood pharmacy now offers checks for high blood pressure, cholesterol levels, and diabetes; testing for HIV might be the next addition in service.
-
The Food and Drug Administration (FDA) has cleared the OraQuick In-Home HIV Test for sale directly to consumers, which makes it the first and only rapid over-the-counter (OTC) HIV test approved in the United States.
-
In June 2012, the Centers for Disease Control and Prevention (CDC) released the U.S. Youth Risk Behavior Surveillance Summary (YRBS) for 2011.1 In the first paragraph, say the most significant finding from the report.
-
New research indicates that use of magnetic resonance imaging (MRI) is safe for use in women who rely on such contraceptive methods as intrauterine devices (IUDs) and implants, as well as in women who have tubal microimplants inserted during hysteroscopic sterilization.